U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 021357

Expand all

MULTIHANCE (GADOBENATE DIMEGLUMINE)
2.645GM/5ML (529MG/ML)
Marketing Status: Prescription
Active Ingredient: GADOBENATE DIMEGLUMINE
Proprietary Name: MULTIHANCE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 2.645GM/5ML (529MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021357
Product Number: 001
Approval Date: Nov 23, 2004
Applicant Holder Full Name: BRACCO DIAGNOSTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MULTIHANCE (GADOBENATE DIMEGLUMINE)
5.29GM/10ML (529MG/ML)
Marketing Status: Prescription
Active Ingredient: GADOBENATE DIMEGLUMINE
Proprietary Name: MULTIHANCE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 5.29GM/10ML (529MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021357
Product Number: 002
Approval Date: Nov 23, 2004
Applicant Holder Full Name: BRACCO DIAGNOSTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MULTIHANCE (GADOBENATE DIMEGLUMINE)
7.935GM/15ML (529MG/ML)
Marketing Status: Prescription
Active Ingredient: GADOBENATE DIMEGLUMINE
Proprietary Name: MULTIHANCE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 7.935GM/15ML (529MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021357
Product Number: 003
Approval Date: Nov 23, 2004
Applicant Holder Full Name: BRACCO DIAGNOSTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
MULTIHANCE (GADOBENATE DIMEGLUMINE)
10.58GM/20ML (529MG/ML)
Marketing Status: Prescription
Active Ingredient: GADOBENATE DIMEGLUMINE
Proprietary Name: MULTIHANCE
Dosage Form; Route of Administration: INJECTABLE; INTRAVENOUS
Strength: 10.58GM/20ML (529MG/ML)
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N021357
Product Number: 004
Approval Date: Nov 23, 2004
Applicant Holder Full Name: BRACCO DIAGNOSTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top